Guided Healthcare’s patent-pending Touch-Free Medical Treatment (TFMT) technology leverages advanced AI and machine learning to to transform direct-to-consumer (DTC) healthcare. TFMT streamlines the patient journey—from lab testing and telemedicine to customized treatment plans—offering precision and convenience without the need for in-person interactions.

With AI predictive analytics, TFMT brings evidence-based medicine to the forefront of DTC healthcare. By analyzing extensive patient data—demographics, medical history, diagnostic tests, and treatment outcomes—TFMT delivers highly personalized and safe treatments backed by robust clinical insights.

Why TFMT Matters:

• Scalable Impact: TFMT addresses a growing market demand for telemedicine and personalized care.
• Market Differentiation: This touch-free, AI-driven platform sets a new benchmark for convenience, efficiency, and patient outcomes.
• Broad Applications: Designed for DTC healthcare applications requiring evidence-based protocols to manage and treat chronic conditions effectively.
• Data-Driven Precision: The platform’s AI-driven approach ensures effective, evidence-backed care, positioning Guided Healthcare as an innovator in digital healthcare solutions.

TFMT offers investors an opportunity to support an innovative technology that aligns with healthcare’s shift toward AI-powered, patient-centric solutions.

Learn More

To dive deeper into the innovation behind TFMT, visit Guided Healthcare or explore our patent detail here.